JH

Jeff Held

Chief Legal Officer

Zenas BioPharma

Zenas BioPharma Pipeline

DrugIndicationPhase
ObexelimabIgG4-Related Disease (IgG4-RD)Phase 3
OrelabrutinibPrimary Immune Thrombocytopenia (ITP)Phase 3
ZB021Undisclosed Autoimmune IndicationPreclinical
ZB022Undisclosed Autoimmune IndicationPreclinical